Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

Loading...
Thumbnail Image
Access rights
openAccess
Journal Title
Journal ISSN
Volume Title
A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
Date
2020-11-19
Major/Subject
Mcode
Degree programme
Language
en
Pages
12
Series
FRONTIERS IN IMMUNOLOGY, Volume 11
Abstract
Rheumatoid arthritis (RA) is a complex autoimmune disease targeting synovial joints. Traditionally, RA is divided into seropositive (SP) and seronegative (SN) disease forms, the latter consisting of an array of unrelated diseases with joint involvement. Recently, we described a severe form of SN-RA that associates with characteristic joint destruction. Here, we sought biological characteristics to differentiate this rare but aggressive anti-citrullinated peptide antibody-negative destructive RA (CND-RA) from early seropositive (SP-RA) and seronegative rheumatoid arthritis (SN-RA). We also aimed to study cytotoxic CD8+ lymphocytes in autoimmune arthritis. CND-RA, SP-RA and SN-RA were compared to healthy controls to reveal differences in T-cell receptor beta (TCRβ) repertoire, cytokine levels and autoantibody repertoires. Whole-exome sequencing (WES) followed by single-cell RNA-sequencing (sc-RNA-seq) was performed to study somatic mutations in a clonally expanded CD8+ lymphocyte population in an index patient. A unique TCRβ signature was detected in CND-RA patients. In addition, CND-RA patients expressed higher levels of the bone destruction-associated TNFSF14 cytokine. Blood IgG repertoire from CND-RA patients recognized fewer endogenous proteins than SP-RA patients’ repertoires. Using WES, we detected a stable mutation profile in the clonally expanded CD8+ T-cell population characterized by cytotoxic gene expression signature discovered by sc-RNA-sequencing. Our results identify CND-RA as an independent RA subset and reveal a CND-RA specific TCR signature in the CD8+ lymphocytes. Improved classification of seronegative RA patients underlines the heterogeneity of RA and also, facilitates development of improved therapeutic options for the treatment resistant patients.
Description
| openaire: EC/H2020/765937/EU//CINCHRON | openaire: EC/H2020/862011/EU//STRATIFY | openaire: EC/H2020/677943/EU//DynaOmics | openaire: EC/H2020/675395/EU//ENLIGHT-TEN
Keywords
ACPA-negative, CD8+ lymphocyte, rheumatoid arthritis, seronegative, somatic mutation, T cell receptor
Other note
Citation
Kelkka, T, Savola, P, Bhattacharya, D, Huuhtanen, J, Lönnberg, T, Kankainen, M, Paalanen, K, Tyster, M, Lepistö, M, Ellonen, P, Smolander, J, Eldfors, S, Yadav, B, Khan, S, Koivuniemi, R, Sjöwall, C, Elo, L L, Lähdesmäki, H, Maeda, Y, Nishikawa, H, Leirisalo-Repo, M, Sokka-Isler, T & Mustjoki, S 2020, ' Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature ', FRONTIERS IN IMMUNOLOGY, vol. 11, 578848 . https://doi.org/10.3389/fimmu.2020.578848